Premium
What causes hidradenitis suppurativa ?—15 years after
Author(s) -
Zouboulis Christos C.,
Benhadou Farida,
Byrd Angel S.,
Chandran Nisha S.,
GiamarellosBourboulis Evangelos J.,
Fabbrocini Gabriella,
Frew John W.,
Fujita Hideki,
GonzálezLópez Marcos A.,
Guillem Philippe,
Gulliver Wayne P. F.,
Hamzavi Iltefat,
Hayran Yildiz,
Hórvath Barbara,
Hüe Sophie,
Hunger Robert E.,
Ingram John R.,
Jemec Gregor B.E.,
Ju Qiang,
Kimball Alexa B.,
Kirby Joslyn S.,
Konstantinou Maria P.,
Lowes Michelle A.,
MacLeod Amanda S.,
Martorell Antonio,
Marzano Angelo V.,
Matusiak Łukasz,
Nassif Aude,
Nikiphorou Elena,
Nikolakis Georgios,
Nogueira da Costa André,
Okun Martin M.,
Orenstein Lauren A.V.,
Pascual José Carlos,
Paus Ralf,
Perin Benjamin,
Prens Errol P.,
Röhn Till A.,
Szegedi Andrea,
Szepietowski Jacek C.,
Tzellos Thrasyvoulos,
Wang Baoxi,
van der Zee Hessel H.
Publication year - 2020
Publication title -
experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.108
H-Index - 96
eISSN - 1600-0625
pISSN - 0906-6705
DOI - 10.1111/exd.14214
Subject(s) - hidradenitis suppurativa , dermatology , medicine , the renaissance , disease , pathology , art history , art
The 14 authors of the first review article on hidradenitis suppurativa (HS) pathogenesis published 2008 in EXPERIMENTAL DERMATOLOGY cumulating from the 1st International Hidradenitis Suppurativa Research Symposium held March 30–April 2, 2006 in Dessau, Germany with 33 participants were prophetic when they wrote “Hopefully, this heralds a welcome new tradition: to get to the molecular heart of HS pathogenesis, which can only be achieved by a renaissance of solid basic HS research, as the key to developing more effective HS therapy.” (Kurzen et al. What causes hidradenitis suppurativa? Exp Dermatol 2008;17:455). Fifteen years later, there is no doubt that the desired renaissance of solid basic HS research is progressing with rapid steps and that HS has developed deep roots among inflammatory diseases in Dermatology and beyond, recognized as “the only inflammatory skin disease than can be healed”. This anniversary article of 43 research‐performing authors from all around the globe in the official journal of the European Hidradenitis Suppurativa Foundation e.V. (EHSF e.V.) and the Hidradenitis Suppurativa Foundation, Inc (HSF USA) summarizes the evidence of the intense HS clinical and experimental research during the last 15 years in all aspects of the disease and provides information of the developments to come in the near future.